Latest Avastin news
Glaucoma Surgery Risk Up With 7+ Injections of Bevacizumab
by modernClinician Editorial Team
Seven or more injections of bevacizumab annually is associated with increased risk of glaucoma surgery, according to a study published online March 16 in JAMA Ophthalmology.
Radiomic-Based Method Predicts Recurrent Glioblastoma Outcome
by modernClinician Editorial Team
A radiomic-based approach can be used to generate a prediction model for stratifying treatment outcome among patients with recurrent glioblastoma prior to bevacizumab treatment, according to a study published online Oct. 10 in Clinical Cancer Research.
Aflibercept, Ranibizumab Not Cost-Effective Vs. Bevacizumab
by modernClinician Editorial Team
Compared with bevacizumab, aflibercept and ranibizumab are not cost-effective for diabetic macular edema, according to research published online June 9 in JAMA Ophthalmology.
Bevacizumab Use in Preemies Associated With Disabilities
by modernClinician Editorial Team
Bevacizumab (Avastin) used to treat retinopathy of prematurity may be linked to serious disabilities such as cerebral palsy and hearing loss, according to a study published online March 17 in Pediatrics.
Editor's Recommendations
Glyphosate Exposure During Pregnancy Linked to Preterm Birth 
Family-Based Behavioral Treatment Improves Child Weight Outcomes 
Adverse Pregnancy Outcomes Linked to Increased Risk for Peripheral Artery Disease 
Very Preterm Birth, Very Low Birth Weight Linked to Lower Positive Functioning in Early Adulthood Related Articles
Bevacizumab, Triamcinolone Up Outcome After Cataract Surgery Monthly Specialist Briefings
Stay Connected
